Launch week offerEnds in00h00m00s

annual Promonthly Pro

Sanna Pasonen-Seppänen

Senior Lecturer

University of Eastern Finland

Finland

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Finland Professors in Immunology Immunology professors in Finland

Articles (11)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (9)

Ville Paakinaho

Assistant Professor (tenure track)

University of Eastern Finland

FINLAND

View details

Mustafa Beter

University of Eastern Finland

FINLAND

View details

Kirsi Rilla

Associate professor

University of Eastern Finland

FINLAND

View details

Lisa Gawriyski

University of Helsinki

FINLAND

View details

Redouane Aherrahrou

Augusta University

UNITED STATES

View details

Emilia Kansanen

Head of Research and Innovation

University of Eastern Finland

FINLAND

View details

Anna-Liisa Levonen

University of Eastern Finland

FINLAND

View details

Simone Adinolfi

University of Eastern Finland

FINLAND

View details

Einari Niskanen

University Lecturer at University of Eastern Finland

University of Eastern Finland

FINLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sanna Pasonen-Seppänen

Research Interests

Make your next move.

Explore related searches

Articles (11)

The Long-Term Sequelae and Clinical Workload Resulting from Toxicities of Immune Checkpoint Inhibitor (ICI) Therapy in Patients with Cancer.

Evaluation of the predictive and prognostic potential of blood immune cell profiles in metastatic cancer patients treated with immune checkpoint inhibitors.

Extracellular vesicles derived from pro-inflammatory M1 macrophages induce an inflammatory and invasive phenotype in melanoma cells

Hyaluronan accumulation is associated with reduced hyaluronidase expression in renal cell carcinoma, with CD44, HAS1, and HYAL2 emerging as prognostic markers.

Poor survival of metastatic cancer patients hospitalized due to immune checkpoint inhibitor-related adverse events.

Translatome profiling reveals Itih4 as a novel smooth muscle cell-specific gene in atherosclerosis

Secreted factors from M1 macrophages drive prostate cancer stem cell plasticity by upregulating NANOG, SOX2 , and CD44 through NFκB-signaling

Oncogenic KEAP1 mutations activate TRAF2-NFκB signaling to prevent apoptosis in lung cancer cells

Expression of Programmed Death Ligand 1 and Indoleamine 2,3-Dioxygenase in Oral Lichen Planus and Oral Lichenoid Lesions.

Differential expression analysis identifies a prognostically significant extracellular matrix-enriched gene signature in hyaluronan-positive clear cell renal cell carcinoma.

A practical prognostic peripheral blood-based risk model for the evaluation of the likelihood of a response and survival of metastatic cancer patients treated with immune checkpoint inhibitors.

Collaborators (9)

Ville Paakinaho

Mustafa Beter

Kirsi Rilla

Lisa Gawriyski

Redouane Aherrahrou

Emilia Kansanen

Anna-Liisa Levonen

Simone Adinolfi

Einari Niskanen

Make your next move.